ARIUS RESEARCH

arius-research-logo

ARIUS Research, Inc., a biotechnology company, engages in the discovery and development of antibody therapeutics primarily focusing on breast, prostate, ovarian, colorectal, pancreatic and lung cancers, leukemia, and melanoma. It identifies monoclonal antibodies targeting various cancer indications through its technology platform, FunctionFIRST. The company's product pipeline includes CD63 program that is in preclinical studies for various cancer indications; ARH460-16-2, an antibody targeting t... he cancer stem cell antigen CD44; AR36A36.11.1 and AR10A304.7, which targets the complement-inhibitory molecule CD59; AR47A6.4.2 and AR52A301.5, which are monoclonal antibodies directed to the cancer-associated protein TROP-2 that is homologous to human EpCAM, an another cell surface cancer related protein; and AR40A746.2.3 that targets leukemia cancer stem cells. It also has antibody programs targeting the MCSP antigen and 37LRP. ARIUS has partnerships with Oxford BioMedica plc, Xerion Pharmaceuticals AG, PDL BioPharma, Inc., Medarex, Inc., Genentech, Inc., and Takeda Pharmaceutical Company Limited. The company was founded in 1999 and is based in Toronto, Canada. As of September 23, 2008, Arius Research Inc. operates as a subsidiary of Roche Holding AG.

#SimilarOrganizations #People #Financial #Website #More

ARIUS RESEARCH

Industry:
Biotechnology Health Care Hospital Therapeutics

Founded:
1999-01-01

Address:
Toronto, Ontario, Canada

Country:
Canada

Website Url:
http://www.ariusresearch.com

Total Employee:
11+

Status:
Closed

Contact:
416-862-2323

Total Funding:
23.5 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Nginx DoubleClick.Net CloudFront Google Adsense AdBlock Acceptable Ads Google Adsense For Domains Trellian


Similar Organizations

affini-t-therapeutics-logo

Affini-T Therapeutics

Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.

cocrystal-discovery-logo

Cocrystal Discovery

Cocrystal Discovery is a biotechnology company developing antiviral therapeutics for human diseases.

intradigm-corporation-logo

Intradigm Corporation

Intradigm Corporation is a biotechnology company developing systematic RNA interference therapeutics.

lenstec-logo

Lenstec

Lenstec is a biotechnology company located in Saint Petersburg.

meditope-biosciences-logo

Meditope Biosciences

Meditope Biosciences is a biotechnology company focused on developing antibody-based cancer therapeutics.

nervesolutions-logo

NerveSolutions

NerveSolutions is a biomedical technology company innovating implantable nerve interface devices.

not_available_image

ORGANIC GENOMICS

ORGANIC GENOMICS is a biotechnology company for developing health care products of therapeutic proteins.

Current Employees Featured

warren-whitehead_image

Warren Whitehead
Warren Whitehead CFO @ Arius Research
CFO

not_available_image

David S. Young
David S. Young Founder @ Arius Research
Founder

Founder


not_available_image

David S. Young

Investors List

efficacy-capital_image

Efficacy Capital

Efficacy Capital investment in Venture Round - Arius Research

xmark-opportunity-funds_image

Xmark Opportunity Funds

Xmark Opportunity Funds investment in Venture Round - Arius Research

orbimed-advisors_image

OrbiMed

OrbiMed investment in Venture Round - Arius Research

xmark-asset-management_image

Xmark Asset Management

Xmark Asset Management investment in Venture Round - Arius Research

Official Site Inspections

http://www.ariusresearch.com

  • Host name: lb-182-253.above.com
  • IP address: 103.224.182.253
  • Location: Australia
  • Latitude: -33.494
  • Longitude: 143.2104
  • Timezone: Australia/Sydney

Loading ...

More informations about "Arius Research"

ARIUS Research Inc. - Toronto, Canada - bionity.com

Feb 20, 2008 ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, โ€ฆSee details»

Arius Research - Crunchbase Company Profile & Funding

ARIUS Research, Inc., a biotechnology company, engages in the discovery and development of antibody therapeutics primarily focusing on breast, prostate, ovarian, colorectal, pancreatic โ€ฆSee details»

Home [www.www.argusresearch.com]

Housing Feeling Weight of Rates According to the National Association of Homebuilders, the expectations of homebuilders for future sales declined in January after six consecutive โ€ฆSee details»

Argus Research Corporation

Argus Research is a leading independent investment research organization providing quality research since 1934. Argus analysts, economists, and portfolio strategists forecast and โ€ฆSee details»

Benefits Of Argus

Woman-Owned Business. We are a division of Argus Investors' Counsel, Inc. (AIC). AIC has been certified as a Women's Business Enterprise by the Women Presidents' Educational Organization.See details»

ARIUS Research - Ownership and Business Overview | Mergr

Jul 23, 2008 ARIUS Research, Inc. is a biotechnology company discovering and developing the next wave of antibody therapeutics to treat cancer and other diseases. At the core of the โ€ฆSee details»

Argus Research - LinkedIn

Argus Research Financial Services Argus Research Co. provides objective, independent financial-market research, analytics, data and advice to investors.See details»

Argus Research - Crunchbase Company Profile & Funding

Argus Research is an investment and financial research company that offers bespoke study in risk analysis, equity and commodities market.See details»

Arius Research Inc - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Arius Research Inc of Mississauga, ON. Get the latest business insights from Dun & Bradstreet.See details»

Argus Research Corporation - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Argus Research Corporation of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»

Argus Investors' Counsel

Argus Investors' Counsel Inc. (AIC) is the money management division of The Argus Research Group and has been an SEC-registered investment advisor since 1960. AIC specializes in โ€ฆSee details»

About Argus - Argus Research

Argus Research Company (www.ArgusResearch.com) Argus Research is a forward-thinking, long-standing independent investment research firm that offers forecasts and ratings on the โ€ฆSee details»

Argus Investors' Counsel : About Us

Argus Investors' Counsel is the asset management arm of The Argus Research Group. We specialize in equity investment management for institutional and private investors. Our clients โ€ฆSee details»

Argus Research Group | Argus Group - ArgusVickers

The Argus Research Group of companies are a leading global provider of research, information and advice on shareholderโ€™s equitySee details»

Home [www.www.www.www.argusresearch.com]

Options in Global Sovereign Debt The benchmark U.S. 10-year Treasury bond yield is near 4.5%. The yield was headed toward the key 5% threshold in April on hotter-than-expected inflation โ€ฆSee details»

About Argus Research | IntelligentCrowd

Argus Research is a forward-thinking, long-standing independent investment research firm that offers forecasts and ratings on hundreds of leading blue chip companies and the U.S. โ€ฆSee details»

Argus Research Corporation Company Profile -Sales, Contacts ...

Argus Research Corporation is located in New York, New York. This organization primarily operates in the Miscellaneous Publishing business / industry within the Printing, Publishing โ€ฆSee details»

About Argus Research Corporation - moneyshow.com

Argus Research is a leading independent investment research organization providing quality research since 1934. Argus analysts, economists, and portfolio strategists forecast and โ€ฆSee details»

ARGUS RESEARCH 2025 OUTLOOK

Dec 4, 2024 DISCLAIMER The Argus trademark, service mark and logo are the intellectual property of The Argus Research Group, Inc. Investing in any security or investment strategy โ€ฆSee details»

Home [stocks.www.argusresearch.com]

Growth Forecast for Clean Energy The emergence of Artificial Intelligence and the growth of the data centers that support the process point toward robust prospects for the power generation โ€ฆSee details»

linkstock.net © 2022. All rights reserved